Showing results (101-110 of 277) with videos related to

Sort By:
Pageof 28
Cardiovascular Drugs and Therapy|April 27, 2004
Limitation of myocardial reperfusion injury by AMP579, an adenosine A1/A2A receptor agonist: role of A2A receptor and Erk1/2Adrienn Kis, Gary F Baxter, Derek M Yellon
Experimental Gerontology|May 29, 2007
Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertensionZaileen Ebrahim, Derek M Yellon, Gary F Baxter
British Journal of Pharmacology|March 19, 2003
Role of nuclear factor-kappa B activation in acute ischaemia-reperfusion injury in myocardiumAdrienn Kis, Derek M Yellon, Gary F Baxter
Journal of Cardiovascular Pharmacology|March 20, 2009
Metformin prevents myocardial reperfusion injury by activating the adenosine receptorMarta Paiva, Niels P Riksen, Sean M Davidson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 18, 2002
Adenosine A(3) receptor activation protects the myocardium from reperfusion/reoxygenation injuryHelen L Maddock, Mihaela M Mocanu, Derek M Yellon
Journal of Cardiovascular Pharmacology|February 24, 2005
Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signalingChristopher A Efthymiou, Mihaela M Mocanu, Derek M Yellon
Basic Research in Cardiology|May 29, 2007
Ischemic preconditioning targets the reperfusion phaseDerek J Hausenloy, Abigail M Wynne, Derek M Yellon
Pageof 28